CD4⁺ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma.
about
Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple Myeloma.Lenalidomide overcomes the immunosuppression of regulatory CD8+CD28- T-cells.Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T-cell immune responses via PD-1/PD-L1 pathway.Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation.
P2860
CD4⁺ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CD4⁺ T cells play a crucial ro ...... ty in murine multiple myeloma.
@ast
CD4⁺ T cells play a crucial ro ...... ty in murine multiple myeloma.
@en
type
label
CD4⁺ T cells play a crucial ro ...... ty in murine multiple myeloma.
@ast
CD4⁺ T cells play a crucial ro ...... ty in murine multiple myeloma.
@en
prefLabel
CD4⁺ T cells play a crucial ro ...... ty in murine multiple myeloma.
@ast
CD4⁺ T cells play a crucial ro ...... ty in murine multiple myeloma.
@en
P2093
P2860
P356
P1433
P1476
CD4⁺ T cells play a crucial ro ...... ty in murine multiple myeloma.
@en
P2093
Chengyun Zheng
Enguang Bi
Jianfei Qian
Liang Zhang
Michael Wang
Sungyoul Hong
P2860
P304
36032-36040
P356
10.18632/ONCOTARGET.5506
P407
P577
2015-10-03T00:00:00Z